C2 Pharma Menu
  • Products
      • c2p_navi_products_APIsProducts Image
      • Products
      • APIs
      • R&D PIPELINE
  • Services
  • Company
      • c2pharma_navi_aboutCompany Image
      • Company
      • ABOUT US
      • NETWORK
      • CAREERS
  • News
  • Contact

Author: c2p-editor

Andrew Badrot, C2 PHARMA CEO, speaking on working to mitigate risks for future crises like the COVID-19 pandemic

Posted on 18. December 202018. December 2020 by c2p-editor

 

Posted in General

Interview with Andrew Badrot, C2 PHARMA CEO, a “Lëtzebuerger Merkur” Featured Story

Posted on 19. November 2020 by c2p-editor
Posted in General

C2 PHARMA Finalist in Excellence in Pharma: Sustainability, the CPhI Pharma Awards 2020

Posted on 23. September 202028. September 2020 by c2p-editor
Posted in General

The Impact of Covid-19 on the Pharmaceutical Industry

Posted on 31. August 20201. September 2020 by c2p-editor
Posted in General

Andrew Badrot, CEO at C2 PHARMA speaking on Connecting industry across the globe, a Chemicals Knowledge Featured Story

Posted on 27. August 20201. September 2020 by c2p-editor
Posted in General

Andrew Badrot, CEO of C2 PHARMA, speaking on how the pharma industry has responded to the COVID-19 pandemic, a Pharma’s Almanac Q2 issue

Posted on 1. July 20207. July 2020 by c2p-editor
Posted in General

Lessons from a modern-day pandemic: redesigning the pharmaceutical supply chain, a Manufacturing Chemist featured story

Posted on 15. May 20207. July 2020 by c2p-editor
Posted in General

COVID-19/Coronavirus is reshaping the pharmaceutical supply chain

Posted on 27. April 20207. July 2020 by c2p-editor
Posted in General

C2 PHARMA Opens Government and Research Access to Safety Stock of DIGOXIN API for Use in Potential COVID-19/Coronavirus Combination Treatment

Posted on 26. March 20207. July 2020 by c2p-editor
Posted in General

Andrew Badrot, CEO of C2 PHARMA, weighing in on the future trends of mergers and acquisitions in the life sciences industry

Posted on 19. March 20207. July 2020 by c2p-editor
Posted in General

C2 PHARMA Expands Advisory Board to Support Growth Objectives

Posted on 3. March 20207. July 2020 by c2p-editor
Posted in Press Release

C2 PHARMA highlights importance of API quality

Posted on 19. February 20207. July 2020 by c2p-editor
Posted in General

Fairness in the pharma supply chain key to success in today’s business climate

Posted on 9. January 20202. October 2020 by c2p-editor
Posted in General

Andrew Badrot, CEO of C2 PHARMA, speaking on developing technologies that will have the greatest impact on the biopharma industry in 2020 and beyond, a Pharma’s Almanac Q4 issue

Posted on 6. December 20197. July 2020 by c2p-editor
Posted in General

C2 PHARMA continues to expand API portfolio

Posted on 6. November 20192. October 2020 by c2p-editor
Posted in General

C2 PHARMA Continues to Expand API Portfolio with Digoxin Micronized Grade, Homatropine Hydrobromide and Multiple Products Under Tech Transfer and Development

Posted on 4. November 20198. November 2019 by c2p-editor
Posted in General

C2 PHARMA leveraging virtual manufacturing to build secure supply chains, a Chemicals Knowledge featured story

Posted on 2. September 20192. October 2020 by c2p-editor
Posted in General

Why the industry is forming bonds with CBD

Posted on 1. July 2019 by c2p-editor
Posted in General

Building resilient supply chains for niche APIs How C² PHARMA overcame the Digoxin challenge

Posted on 6. June 20197. June 2019 by c2p-editor
Posted in General

C2 PHARMA Acquires Digoxin API Portfolio from Nobilus Ent

Posted on 20. March 201920. March 2019 by c2p-editor
Posted in Press Release

Recent Posts

  • Andrew Badrot, C2 PHARMA CEO, speaking on working to mitigate risks for future crises like the COVID-19 pandemic
  • Interview with Andrew Badrot, C2 PHARMA CEO, a “Lëtzebuerger Merkur” Featured Story
  • C2 PHARMA Finalist in Excellence in Pharma: Sustainability, the CPhI Pharma Awards 2020
  • The Impact of Covid-19 on the Pharmaceutical Industry
  • Andrew Badrot, CEO at C2 PHARMA speaking on Connecting industry across the globe, a Chemicals Knowledge Featured Story

Archives

  • December 2020
  • November 2020
  • September 2020
  • August 2020
  • July 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • September 2019
  • July 2019
  • June 2019
  • March 2019
  • November 2018
  • October 2018
  • June 2018
  • October 2017
  • September 2017
  • September 2016
  • October 2015
  • September 2015
  • May 2015
  • March 2015
  • January 2015
  • September 2014
  • July 2014

Categories

  • General
  • Press Release

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
  • APIs

    • Atropine base
    • Atropine Sulfate
    • Digoxin and Digoxin Micron
    • Homatropine Methylbromide
    • Pilocarpine Hydrochloride and Nitrate
    • Scopolamine butylbromide
  • R&D Pipeline
  • Services
  • About Us
  • Network
  • Careers
  • News
  • CONTACT

C-squared PHARMA S.à r.l.

Administration Department
270 rue de Neudorf
L-2222 Luxembourg
Grand Duchy of Luxembourg

T +352 28 26 1100
info@c2pharma.com
www.c2pharma.com

C2Pharma Logo
  • General Terms of Sales
  • Data Privacy